<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E29E26FC-3B0D-4349-8758-A476A67D7F47"><gtr:id>E29E26FC-3B0D-4349-8758-A476A67D7F47</gtr:id><gtr:name>The Leducq Foundation (Fondation Leducq)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Cardiovascular</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E29E26FC-3B0D-4349-8758-A476A67D7F47"><gtr:id>E29E26FC-3B0D-4349-8758-A476A67D7F47</gtr:id><gtr:name>The Leducq Foundation (Fondation Leducq)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F93131C2-9CE4-4B62-AB5B-77A4C668934F"><gtr:id>F93131C2-9CE4-4B62-AB5B-77A4C668934F</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Eaton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK003232%2F1"><gtr:id>6A275C17-565B-4A98-9B7F-A2BD410EC777</gtr:id><gtr:title>Protein kinase G Ialpha disulfide oxidation and the pathogenesis of sepsis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K003232/1</gtr:grantReference><gtr:abstractText>Sepsis, often referred to as blood poisoning, occurs when bacteria get into the blood stream. This is a very common disease and when it occurs the chances of survival are rather poor. Major issues in sepsis are that the patient blood pressure becomes very low and their blood vessels become leaky. Together this causes a lot of harm and many of the bodies organs are not supplied with enough blood and so they become injured. Recently we identified a new pathway that lowers blood pressure in healthy people. We have some preliminary evidence this mechanism becomes overactive in sepsis to uncontrollably and overly lower blood pressure. We will test if this is true and try and identify strategies that prevent this from happening as these may be protective to humans with sepsis.</gtr:abstractText><gtr:technicalSummary>Sepsis is a common and often deadly medical condition that exerts an enormous burden on healthcare systems. Previously we showed that PKGIalpha can be activated by oxidative stress independently of the classical NO-cGMP activation pathway. This alternate activation pathway involves oxidants inducing a disulfide bond between the kinases two subunits. This is potentially relevant to sepsis as it is a time of oxidative stress that may drive formation of the disulfide and this would explain the associated hypotension that causes injury. Consistent with these ideas we have found PKG disulfide formation occurs in mice following LPS treatment, which strongly supports overall hypothesis. Recently we generated 'redox dead' Cys42Ser PKG knock-in mice that cannot be activated by disulfide oxidation. We propose to compare the response of these mice to their wild-type littermate controls during sepsis. We predict that the knock-in will be protected from sepsis-induced hypotension, as will cardiac, lung and kidney function. Indeed our pilot studies have already shown that the knock-in mice are protected in part from LPS-induced hypotension.</gtr:technicalSummary><gtr:potentialImpactText>Sepsis is a common and often deadly medical condition that exerts an enormous burden on healthcare systems and society. Current therapeutic strategies of administering antibiotics (to combat the underlying infection) or vasopressor (to elevate blood pressure) are often ineffective, with a high risk (approximately 25%) of mortality. In recent years much attention has been paid to the idea that injury during sepsis is driven by over-production of nitric oxide to detrimentally lower blood pressure by activating soluble Guanylate Cyclase and then protein kinase G (PKG). However, clinical trials preventing nitric oxide production during sepsis were ineffective and in fact increased mortality. Clearly our current understanding of the disease is lacking. By better understanding the mechanisms that underlie the dysfunction that occurs in sepsis we improve our chances of implementing or designing rational therapeutic strategies. Our previous work identified an important new way of activating PKG independently of the nitric oxide pathway, involving it becoming oxidised to form an interprotein disulfide. Sepsis is well-known as a time of oxidative stress and so PKG oxidation may be expected to occur. PKG oxidative activation would logically explain the hypotension that occurs during sepsis. Indeed, we found sepsis induces PKG oxidation and this was associated with murine hypotension in vivo. In contrast a Cys42Ser PKG knock-in mouse that cannot be activated by disulfide oxidation was resistant in part to sepsis-induced hypotension. This knock-in model will be invaluable in determining the importance of PKG oxidation in injury during sepsis, as well as helping us understand this at the molecular level. Indeed, by comparing the knock-in responses to their wild-type littermate controls during sepsis, we may be able to identify protective pharmacological treatment that operate by preventing oxidation-induced over-activation of PKG. Overall we have identified a potentially important new mechanism that may be injurious during sepsis, and we propose studies that may lead to therapies that help treat this major healthcare problem.</gtr:potentialImpactText><gtr:fund><gtr:end>2013-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>151405</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>BHF Centre of Research Excellence</gtr:department><gtr:description>KCL BHF Centre</gtr:description><gtr:id>749EDA11-D038-486A-8D27-9B795A1C3063</gtr:id><gtr:impact>Helped gain pilot data for follow-on funding</gtr:impact><gtr:outcomeId>tLK51F2sQHB-1</gtr:outcomeId><gtr:partnerContribution>They provided funds and intelelctuall support.</gtr:partnerContribution><gtr:piContribution>The KCL BHF centre of Resaerch Excellence has provided us funding as part of their mission. Our research using this funding has aided this mission.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Leducq Foundation (Fondation Leducq)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Redox and Nitrosative Regulation of Cardiac Remodeling: Novel Therapeutic Approaches for Heart Failure</gtr:department><gtr:description>Leducq Foundation</gtr:description><gtr:id>A0AC6655-8248-42BB-85BC-E4F8CD27A017</gtr:id><gtr:impact>This funding was key to several publications and has helped generate pilot data for grant applications.</gtr:impact><gtr:outcomeId>Y3dnh2S38mp-1</gtr:outcomeId><gtr:partnerContribution>Funding was provided and they also facilitate regular meetings of the group.</gtr:partnerContribution><gtr:piContribution>We have helped form a team of European / North American resaercghers studying herat failure, and the role of oxidative stress.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>381870</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Does redox state of PKG1alpha control hypoxic vasoconstriction and remodelling in the pulmonary vasculature?</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>9746C451-7621-4AF4-9DA2-F1363A4439E7</gtr:id><gtr:outcomeId>56defe560db538.83148556</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>502927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Disulfide activated protein kinase G Ialpha as a new therapeutic target in sepsis</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>592953CF-4FD5-4C3B-B359-9EE16863A1CA</gtr:id><gtr:outcomeId>56defecab62a68.89773418</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>502927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>Disulfide activated protein kinase G Ialpha as a new therapeutic target in sepsis</gtr:fundingRef><gtr:id>797067A0-F6CA-4675-96D3-069E47C43849</gtr:id><gtr:outcomeId>545ce35a8ce296.09232726</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>381870</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Does redox state of PKG1alpha control hypoxic vasoconstriction and remodelling in the pulmonary vasculature?</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>04AE1490-F532-4BA1-8847-D8B49926C1BC</gtr:id><gtr:outcomeId>56defe5129f7d1.01837535</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>66C900B8-B8AE-49A2-8555-A60577966021</gtr:id><gtr:title>Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dba285335691f3955553a3c3cb4a916b"><gtr:id>dba285335691f3955553a3c3cb4a916b</gtr:id><gtr:otherNames>Hohl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>545a67a6ee1ee6.39731461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1220671-CC4B-4DA7-A906-6487A781F094</gtr:id><gtr:title>S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70876a60151110f3b7628402722e2222"><gtr:id>70876a60151110f3b7628402722e2222</gtr:id><gtr:otherNames>Stathopoulou K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56defaa2d79488.15718198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2372F005-CF40-4E65-BF80-F5592C121E58</gtr:id><gtr:title>Redox-guided axonal regrowth requires cyclic GMP dependent protein kinase 1: Implication for neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Redox biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9bd55c4dc71ebd938da82d6d660db4e"><gtr:id>b9bd55c4dc71ebd938da82d6d660db4e</gtr:id><gtr:otherNames>Valek L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-2317</gtr:issn><gtr:outcomeId>58b94a9faa4336.33325723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF86724F-6709-4169-8F95-241DA792FC37</gtr:id><gtr:title>Analysis of Mitochondrial Proteins in the Surviving Myocardium after Ischemia Identifies Mitochondrial Pyruvate Carrier Expression as Possible Mediator of Tissue Viability.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fc6c914b558105b035d74da8d9f4601"><gtr:id>7fc6c914b558105b035d74da8d9f4601</gtr:id><gtr:otherNames>Fern?ndez-Caggiano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>58b94aa0d504d1.11751345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>619E3FA5-55CF-4CD0-B091-D66B729B72D6</gtr:id><gtr:title>Examining a role for PKG Ia oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2226d4078053c470b78cb99103ef2fa1"><gtr:id>2226d4078053c470b78cb99103ef2fa1</gtr:id><gtr:otherNames>Rudyk O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>5a350407c9c821.25086929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>827C040E-69F1-4EED-AD59-6B5E07B7F087</gtr:id><gtr:title>Intensity matters: Ryanodine receptor regulation during exercise.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35ee8dc76583a4c956e4acac9fe24151"><gtr:id>35ee8dc76583a4c956e4acac9fe24151</gtr:id><gtr:otherNames>Kohl T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56defaa328e556.32038097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F20C4232-EA3F-4CA5-A241-79E6FED9D6CF</gtr:id><gtr:title>Prevention of PKG1a oxidation augments cardioprotection in the stressed heart.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20a8c48cfd96c301d04a1c72dd2a9276"><gtr:id>20a8c48cfd96c301d04a1c72dd2a9276</gtr:id><gtr:otherNames>Nakamura T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>585d5f3fe7d0e9.71632570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D83A56F-A118-4325-8767-44983429FEC1</gtr:id><gtr:title>Oxidant-induced Interprotein Disulfide Formation in Cardiac Protein DJ-1 Occurs via an Interaction with Peroxiredoxin 2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10af7d54eee64eb092c93aff7d0073c1"><gtr:id>10af7d54eee64eb092c93aff7d0073c1</gtr:id><gtr:otherNames>Fernandez-Caggiano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56defaa25ffa19.07829283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A885B8A-325E-4B1A-9CBD-80294C50F2E1</gtr:id><gtr:title>Protein kinase G Ia oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ac8d63c33c1e78333b00b0fead8fefd"><gtr:id>8ac8d63c33c1e78333b00b0fead8fefd</gtr:id><gtr:otherNames>Stubbert D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>545a67a6563389.85701439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D91AB0F8-1680-45ED-9CDE-5732503BCB44</gtr:id><gtr:title>Evidence against Stable Protein S-Nitrosylation as a Widespread Mechanism of Post-translational Regulation.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c9531e1c147448d2c0880c8faaaa47"><gtr:id>34c9531e1c147448d2c0880c8faaaa47</gtr:id><gtr:otherNames>Wolhuter K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5a678ecbc09208.46697748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0676DD5-4B75-4AAC-9211-8242EBA38391</gtr:id><gtr:title>Polarized cell motility induces hydrogen peroxide to inhibit cofilin via cysteine oxidation.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/378976f6c69421839c9d8ae7eb7d2af0"><gtr:id>378976f6c69421839c9d8ae7eb7d2af0</gtr:id><gtr:otherNames>Cameron JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>56defaa3a86b51.74165361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46DF9C85-3DE9-4056-8DFA-1D0FB0D234DB</gtr:id><gtr:title>Redox regulation of cGMP-dependent protein kinase Ia in the cardiovascular system.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b75e7496bfbdbbd17c5211cb3341d3"><gtr:id>72b75e7496bfbdbbd17c5211cb3341d3</gtr:id><gtr:otherNames>Prysyazhna O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>56defaa37d0605.80292859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A48EED97-EA32-4FAF-AE46-F1E82690064F</gtr:id><gtr:title>Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Ia Oxidation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b75e7496bfbdbbd17c5211cb3341d3"><gtr:id>72b75e7496bfbdbbd17c5211cb3341d3</gtr:id><gtr:otherNames>Prysyazhna O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58b94aa0767505.11012247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30A2803E-2DD0-4110-81BD-A8A0CEA8DABF</gtr:id><gtr:title>Preface for redox signalling in the cardiovascular system.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbc495924157071709cab95e71c47f4"><gtr:id>adbc495924157071709cab95e71c47f4</gtr:id><gtr:otherNames>Eaton P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>545a67a6c67e58.97541995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45D6C624-614C-419C-AB7C-60853CA82697</gtr:id><gtr:title>Persistent Activation of cGMP-Dependent Protein Kinase by a Nitrated Cyclic Nucleotide via Site Specific Protein S-Guanylation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2620fe80c290554601066c8856b8aa"><gtr:id>4a2620fe80c290554601066c8856b8aa</gtr:id><gtr:otherNames>Akashi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>56defaa2b42544.90219129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77564E51-6419-4E41-B04D-DEECBC3244CF</gtr:id><gtr:title>Abnormal Remodeling of Subcutaneous Small Arteries Is Associated With Early Diastolic Impairment in Metabolic Syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c73a55756120cce220159e47dab14791"><gtr:id>c73a55756120cce220159e47dab14791</gtr:id><gtr:otherNames>Khavandi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn><gtr:outcomeId>5a35d991e25dc9.19308834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AFBDEF4-CA4D-479A-AB97-AF1FA522B41E</gtr:id><gtr:title>Biochemical methods for monitoring protein thiol redox states in biological systems.</gtr:title><gtr:parentPublicationTitle>Redox biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2226d4078053c470b78cb99103ef2fa1"><gtr:id>2226d4078053c470b78cb99103ef2fa1</gtr:id><gtr:otherNames>Rudyk O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2317</gtr:issn><gtr:outcomeId>545a67a6790496.38090918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98183408-6BFF-46D1-8966-FE3052CBBF70</gtr:id><gtr:title>Deficient angiogenesis in redox-dead Cys17Ser PKARIa knock-in mice.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba3294824d73ad5fba13b933e15d8c21"><gtr:id>ba3294824d73ad5fba13b933e15d8c21</gtr:id><gtr:otherNames>Burgoyne JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56defaa352b189.63004957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B34CA468-2E99-4DFC-A1EC-87578D9E7062</gtr:id><gtr:title>Protein kinase G oxidation is a major cause of injury during sepsis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2226d4078053c470b78cb99103ef2fa1"><gtr:id>2226d4078053c470b78cb99103ef2fa1</gtr:id><gtr:otherNames>Rudyk O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14803_23_23716652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24FEE99E-85C0-495A-9CD6-692C9AB8F645</gtr:id><gtr:title>How widespread is stable protein S-nitrosylation as an end-effector of protein regulation?</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c9531e1c147448d2c0880c8faaaa47"><gtr:id>34c9531e1c147448d2c0880c8faaaa47</gtr:id><gtr:otherNames>Wolhuter K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>58b94a9f3d1542.03958238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F59C6AD-425D-4B05-833B-BB9862261288</gtr:id><gtr:title>Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c73a55756120cce220159e47dab14791"><gtr:id>c73a55756120cce220159e47dab14791</gtr:id><gtr:otherNames>Khavandi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>58b94aa0159e94.04021982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2609087B-E694-43C4-BA23-0EEDCEB41A3A</gtr:id><gtr:title>Transcriptional Regulation of Cystathionine-?-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0963e182a9d434ecd6d81d173c2833f6"><gtr:id>0963e182a9d434ecd6d81d173c2833f6</gtr:id><gtr:otherNames>Mistry RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56defaa2880932.19327739</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K003232/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>